REVELATION BIOSCIENCES, INC. Debt Securities, Held-to-maturity, Transfer to Trading, Unrealized Gain (Loss)
REVELATION BIOSCIENCES, INC. (REVB) reported Debt Securities, Held-to-maturity, Transfer to Trading, Unrealized Gain (Loss) of -$17.36 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-10-29.
Discontinued › Income Statement › Other Income
us-gaap:HeldToMaturitySecuritiesTransferredToTradingSecuritiesUnrealizedGainLoss · last filed 2022-04-15
- REVELATION BIOSCIENCES, INC. debt securities, held-to-maturity, transfer to trading, unrealized gain (loss) for the quarter ending 2021-09-30 was $0.00.
- REVELATION BIOSCIENCES, INC. debt securities, held-to-maturity, transfer to trading, unrealized gain (loss) for the quarter ending 2021-06-30 was $0.00.
- REVELATION BIOSCIENCES, INC. debt securities, held-to-maturity, transfer to trading, unrealized gain (loss) for the quarter ending 2021-03-31 was -$17.36K.
- REVELATION BIOSCIENCES, INC. debt securities, held-to-maturity, transfer to trading, unrealized gain (loss) for fiscal 2020 was -$1.83K.
| Period end | Debt Securities, Held-to-maturity, Transfer to Trading, Unrealized Gain (Loss) 3 month | Debt Securities, Held-to-maturity, Transfer to Trading, Unrealized Gain (Loss) 6 month | Debt Securities, Held-to-maturity, Transfer to Trading, Unrealized Gain (Loss) 9 month | Debt Securities, Held-to-maturity, Transfer to Trading, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $0.00 derived: sum of 2 quarters · filed 2021-10-29 | -$17.36K 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-23 | -$17.36K 10-Q · filed 2021-08-23 | ||
| 2021-03-31 | -$17.36K 10-Q · filed 2021-06-22 | |||
| 2020-12-31 | -$1.83K 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |